Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thromboembolism of Vein VTE in Colorectal Cancer”

5 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 5 of 5 results

Large-scale testing (Phase 3)Study completedNCT02195232
What this trial is testing

Cancer Associated Thrombosis and Isoquercetin (CATIQ)

Who this might be right for
Thromboembolism of Vein VTE in Colorectal CancerThromboembolism of Vein in Pancreatic CancerThromboembolism of Vein in Non-small Cell Lung Cancer
Jeffrey Zwicker, MD 64
Not applicableUnknownNCT04588805
What this trial is testing

Incidence Rate of Perioperiative VTE in Colorectal Cancer Patients : a Multicenter Prospective Observational Cohort Study

Who this might be right for
Incidence Rate of Perioperiative Venous Thromboembolism(VTE) in Colorectal Cancer Patients
Beijing Friendship Hospital 1,217
Not applicableNot Yet RecruitingNCT06583330
What this trial is testing

A Multicenter, Open-Label, Non-Inferiority Randomized Controlled Trial of Postoperative VTE Prevention in Chinese Patients After Colorectal Cancer Surgery

Who this might be right for
Colorectal SurgeryVTE (Venous Thromboembolism)
Beijing Friendship Hospital 1,448
Not applicableStudy completedNCT03099031
What this trial is testing

Non Interventional Study of the Validation of the Ottawa Score in Cancer Patients With Venous Thromboembolism (VTE)

Who this might be right for
Venous Thromboembolism
LEO Pharma 420
Large-scale testing (Phase 3)UnknownNCT01589146
What this trial is testing

ONE WEEK VERSUS FOUR WEEK HEPARIN PROPHYLAXIS AFTER LAPAROSCOPIC SURGERY FOR COLORECTAL CANCER.

Who this might be right for
The Primary Study Objective is to Assess the Efficacy andSafety of Extended 4-week Heparin Prophylaxis Compared toProphylaxis Given for 8±2 Days After Planned Laparoscopic+4 more
University Of Perugia 400